Dune Medical Devices has announced the U.S. release of its MarginProbe System, which was approved by the FDA in January. The University of California, Irvine Medical Center was the first in the U.S. to deploy the system, which is used for tissue evaluation during early-stage breast cancer procedures.
Dune Medical's breast cancer device debuts in U.S.
SmartBrief Job Listings for Health Care
|Director, Product Policy||
America's Health Insurance Plans (AHIP)
|Regional Sales Consultant (Contract Position)||
|Business Developer, Strategic Partnerships (Healthcare)||
Geisinger Health System
|Director Health Plans||
Accreditation Association for Ambulatory Health Care (AAAHC)